West Pharmaceutical Services, Inc.

NYSE:WST

Medical - Instruments & Supplies

Healthcare
$404.02 +1.56%

+$5.04 today

Market cap
$28.14B
Beta
1.18
P/E (TTM)
43.6
EPS (TTM)
$7.54
Dividend yield
0.26%
52W Low $206.80High $336.82

Volume 0.59M

Average 0.85M

WST Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

West Pharmaceutical Services, Inc.NYSE: WST

Change in Working Capital · Q2 FY2026 · quarter ended Jun 2026

Change in working capital turns positive

Q2 FY2026 change in working capital was $102.9M, compared with -$100K a year earlier. Trailing-twelve-month change in working capital was $65.9M.

Context

  • Change in working capital amounted to 2.6% of revenue in FY2025, up 2.5 pp from a year earlier.
  • Change in working capital increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly change in working capital holds near $102.9M or moves back toward the trailing-twelve-month quarterly average of $16.48M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$102.9M+200.0% QoQ
Last fiscal yearDec 2025
$79.8M+2651.7% YoY
LTMJun 2026
$65.9M+181.6% YoY
Change in Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+103000.0%——
1 year+2651.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Change in Working Capital history

USD · from the cash flow

Latest · FY2025
79.8M USD
Year-over-year change
+2651.7%

Change in Working Capital vs competitors

How WST compares with its peers on the latest reported figures

  • Peers report in different currencies, so change in working capital is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +181.6% is the highest of 4, against a peer median of +16.7%.
  • Change in working capital amounts to 2.0% of revenue for WST, versus a peer median of 3.8%.
WST Competitors
Change in Working Capital for WST and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ICUIICU Medical, Inc.LTM Jun 2026$107.49M USD+16.7%-33.3%5.0%
ATRAptarGroup, Inc.LTM Jun 2026$101.67M USD+54.7%+40.7%2.6%
WSTWest Pharmaceutical Services, Inc.LTM Jun 2026$65.9M USD+181.6%—2.0%
BLFSBioLife Solutions, Inc.LTM Mar 2026$12.03M USD—-15.8%12.1%
STVNStevanato Group S.p.A.LTM Jun 2026€4.86M EUR-172.7%—0.4%
Peer median (excluding WST) —+16.7%-15.8%3.8%

Competitors are the stored peer set for WST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income661.8M585.9M593.4M492.7M493.7M
Depreciation & Amortization122.3M120.6M137.3M155.4M171.4M
Deferred Income Tax(42.9M)(30.8M)37.5M0(13.7M)
Stock-Based Compensation37.5M23.7M23.3M18.7M23.8M
Change in Working Capital(193.8M)(15M)(20.4M)2.9M79.8M
Accounts Receivables(123.5M)(35.6M)4M(58.8M)6.9M
Inventory(86.5M)(49.8M)(13.5M)42M(62.8M)
Accounts Payables16.8M(2.8M)4.4M2.9M17.9M
Other Working Capital(600K)73.2M(15.3M)16.8M117.8M
Other Non-Cash Items(900K)36.1M5.4M(16.3M)(200K)
Operating Cash Flow584M724M776.5M653.4M754.8M
Capital Expenditures(253.4M)(284.6M)(362M)(377M)(285.9M)
Acquisitions (Net)(2.2M)0000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities2.5M(3.6M)(6.7M)(1.7M)0
Investing Cash Flow(253.1M)(288.2M)(368.7M)(378.7M)(285.9M)
Debt Repayment(2.2M)(44.3M)(2.3M)(27.6M)(1.1M)
Common Stock Issued000018.2M
Common Stock Repurchased(151.9M)(222.2M)(451.2M)(566.6M)(134M)
Dividends Paid(51.1M)(54.1M)(57M)(59.1M)(61.2M)
Other Financing Activities37.1M27M50.9M30.7M(7M)
Financing Cash Flow(168.1M)(293.6M)(459.6M)(622.6M)(185.1M)
Effect of Forex Changes(15.7M)(10.5M)11.4M(21.4M)22.9M
Net Change in Cash147.1M131.7M(40.4M)(369.3M)306.7M
Free Cash Flow330.6M439.4M414.5M276.4M468.9M

West Pharmaceutical Services, Inc.

NYSE:WST

Intrinsic Alpha fair value

Locked

Current Price

$404.02

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.